Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07007676 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes

Study acronym: INTELLECT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial sites expanded: 15 → 21 locations Collaborators: 17 to 23v4 Show 1 more changeShow less
    • Collaborators: 17 to 23

    See this version in full on ClinicalTrials.gov ↗

  2. Primary completion date: Jul 30, 2026 to Feb 28, 2027 Study sites: 5 to 15 · Completion date: Dec 31, 2026 to Jun 30, 2027 · Collaborators: 7 to 17v3 Show 3 more changesShow less
    • Study sites: 5 to 15
    • Completion date: Dec 31, 2026 to Jun 30, 2027
    • Collaborators: 7 to 17

    See this version in full on ClinicalTrials.gov ↗

  3. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 5 · Primary completion date: Jun 30, 2026 to Jul 30, 2026 · Start date changed from estimate of Jun 15, 2025 to Jul 14, 2025 · 2 morev2 Show 5 more changesShow less
    • Study sites: 0 to 5
    • Primary completion date: Jun 30, 2026 to Jul 30, 2026
    • Start date changed from estimate of Jun 15, 2025 to Jul 14, 2025
    • Eligibility criteria shortened, about 63 words
    • Secondary endpoints: 14 to 5

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if continuous glucose monitoring system works to improve glucose control in non-insulin-treated older adults with type 2 diabetes. The main questions it aims to answer are: * Dose the use of continuous glucose monitoring system improve glucose control in older adults with type 2 diabetes treated with oral antidiabetic drugs only? * Dose the use of continuous glucose monitoring system affect psychological outcomes in older adults with type 2 diabetes treated with oral antidiabetic drugs only? Researchers will compare continuous glucose monitoring to standard blood glucose monitoring to see if continuous glucose monitoring works better in glucose management. Participants will: * Wear continuous glucose monitoring every 2 months or standard blood glucose monitoring for 6 months * Visit the clinic once every 2 months for follow-up * Keep a diary of their blood glucose when continuous glucose monitoring was not used
Trial Details
NCT Number NCT07007676
Lead Sponsor Shanghai 6th People's Hospital
Collaborators: Shenzhen Center for Chronic Disease Control, Shenzhen Baoan District People's Hospital, Shenzhen Haile Community Health Service Station, Shenzhen Buxin Community Health Service Center, Shenzhen Dalang Community Health Service Center, Shenzhen Haihua Community Health Service Center, Shenzhen Pingzhou Community Health Service Center, Shenzhen Fifth Avenue Health Service Station, Shenzhen Haifu Health Service Station, Shenzhen Haile Huafu Health Service Station, Shenzhen Haiyu Health Service Station, Shenzhen Jiaan Health Service Station, Shenzhen Jiari Mingju Health Service Station, Shenzhen Jiangangshan Health Service Center, Shenzhen Xinan Lake Health Service Station, Shenzhen Xingdong Health Service Station, Shenzhen Zhongliang Chuangxin Health Service Station, Shenzhen Guantian Community Health Service Station, Shenzhen Huiyu Mingdu Community Health Service Station, Shenzhen Langxin Community Health Service Station, Shenzhen Luozu Community Health Service Center, Shenzhen Tianbao Community Health Service Center, Shenzhen Shuitian Health Service Center
Conditions Diabetes Mellitus Type 2
Enrollment 148 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov